EGFR and cancer: A contemporary approach for tackling cancer proliferation involves the inhibition of a trans-membrane glycoprotein, identified as epidermal growth factor receptor (EGFR), which contributes a crucial role in intracellular signaling, morphogenesis, and differentiation [13, 14].